{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:58:02Z","timestamp":1760299082693},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.atherosclerosis.2015.02.010","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T17:39:00Z","timestamp":1423330740000},"page":"401-404","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plasma triglyceride determination can identify increased risk of statin-induced type 2 diabetes: A hypothesis"],"prefix":"10.1016","volume":"239","author":[{"given":"J","family":"Armato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Ruby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Reaven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9716","key":"10.1016\/j.atherosclerosis.2015.02.010_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2015.02.010_bib2","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"issue":"9841","key":"10.1016\/j.atherosclerosis.2015.02.010_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"issue":"25 Pt B","key":"10.1016\/j.atherosclerosis.2015.02.010_bib4","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American heart association task Force on practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2010.10.047","article-title":"Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials","volume":"57","author":"DD1","year":"2011","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib7","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. prospective studies of Pima Indians","volume":"329","author":"S1","year":"1993","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1210\/jcem-73-4-866","article-title":"Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians","volume":"73","author":"S1","year":"1991","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/ATVBAHA.111.224790","article-title":"Wanted !. A standardized measurement of plasma insulin concentration","volume":"31","author":"Reaven","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib10","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI105666","article-title":"Role of insulin in endogenous hypertriglyceridemia","volume":"46","author":"Reaven","year":"1967","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0002-9343(74)90006-0","article-title":"Reappraisal of the role of insulin in hypertriglyceridemia","volume":"57","author":"Olefsky","year":"1974","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/01.ATV.13.3.367","article-title":"Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia","volume":"13","author":"Sheu","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib13","article-title":"Statin-induced diabetes: how important is insulin resistance?","author":"Abbasi","year":"2014","journal-title":"J.\u00a0Intern Med."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4158\/EP.14.7.933","article-title":"Diagnosis and management of prediabetes in the continuum of hyperglycemia\u2014when do the risks of diabetes begin? A consensus statement from the American College of Endocrinologists and the American Association of Clinical Endocrinologists","volume":"14","author":"Garber","year":"2008","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low- density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"Suppl.\u00a0l 1","key":"10.1016\/j.atherosclerosis.2015.02.010_bib16","first-page":"S11","article-title":"American diabetes association standards of medical care in diabetes\u20132013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-013-0461-2","article-title":"Evaluation of fasting plasma insulin concentration as an estimate of insulin action in nondiabetic individuals: comparison with the homeostasis model assessment of insulin resistance (HOMA-IR)","volume":"51","author":"Abbasi","year":"2014","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib18","doi-asserted-by":"crossref","first-page":"41241","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib19","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"20","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib21","first-page":"2486","article-title":"Evaluation, and treatment of high blood cholesterol in adults","volume":"285","author":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection","year":"2001","journal-title":"Adult Treat. Panel III. JAMA"},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib22","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of Dyslipidaemias","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"WC1","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ecl.2004.12.001","article-title":"Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals","volume":"34","author":"Reaven","year":"2005","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9149(99)00604-9","article-title":"High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk","volume":"85","author":"Abbasi","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib26","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and Cardiovascular Disease A Scientific statement from the American heart association","volume":"123","author":"M1","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0735-1097(02)02051-X","article-title":"Relationship between obesity, insulin resistance, and coronary heart disease risk","volume":"40","author":"Abbasi","year":"2002","journal-title":"J.\u00a0Am. Coll. Card."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","article-title":"Is there a simple way to identify insulin- resistant individuals at increased risk of cardiovascular disease?","volume":"96","author":"McLaughlin","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.02.010_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archinte.166.2.249-a","article-title":"Why the plasma TG\/HDL-c concentration ratio does not predict insulin resistance in African Americans","volume":"166","author":"Reaven","year":"2006","journal-title":"Arch. Intern Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015001008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015001008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T19:31:24Z","timestamp":1598729484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015001008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0021915015001008"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.02.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma triglyceride determination can identify increased risk of statin-induced type 2 diabetes: A hypothesis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}